Translational Neural Devices (U44 Clinical Trial Optional)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster <br/>grantsinfo@nih.gov
grantsinfo@nih.gov

Key dates & funding
  • PostedApr 28, 2021
  • ClosesDec 20, 2022
  • Award ceiling$1,000,000
  • Program funding$4,000,000
  • CFDA93.853
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro